DEKETRA MCDOWELL-WILLIS: Open Payments
NPI 1124429386 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,073 in 42 payments from 8 companies in 2025. Trend: 2023 $488 · 2024 $795 · 2025 $2,073
Consulting: $1,105Food & beverage: $839Education: $129
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $912 |
| Verona Pharma, Inc. | 13 | $660 |
| AstraZeneca Pharmaceuticals LP | 8 | $226 |
| SANOFI-AVENTIS U.S. LLC | 1 | $79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $70 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Electromed, Inc. | 4 | $38 |
| Amgen Inc. | 1 | $34 |
Products named: Ohtuvayre, DUPIXENT, BREZTRI, AIRSUPRA, OFEV, SMARTVEST, TRELEGY ELLIPTA, JASCAYD.
Industry payments across NV — which companies pay providers there.
